Biomarkers for Women After Cervical Cancer Screening
Author Information
Author(s): Ovestad Irene T., Dalen Ingvild, Soreng Kristiane, Akbari Saleha, Lapin Morten, Janssen Emiel AM, Austdal Marie, Munk Ane Cecilie, Gudlaugsson Einar
Primary Institution: Stavanger University Hospital, Norway
Hypothesis
Can gene expression levels associated with immune response and proliferation serve as biomarkers for women following cervical cancer screening?
Conclusion
The study identified specific gene expression markers that can help differentiate between women who need immediate follow-up after cervical cancer screening and those who do not.
Supporting Evidence
- Four genes were identified as potential biomarkers for differentiating between CIN3 and normal tissue.
- Statistically significant differences in gene expression were found between high oncogenic potential HPV and low oncogenic potential HPV.
- Models combining gene expression levels with HPV classification improved discrimination of CIN2/3 versus CIN1.
Takeaway
Scientists found certain genes that can help doctors tell if women need a biopsy after a cervical cancer test, which can help avoid unnecessary procedures.
Methodology
The study used next-generation sequencing and quantitative PCR to analyze gene expression in cervical biopsies.
Potential Biases
Potential bias due to the retrospective nature of some cohorts and the quality of archived tissue samples.
Limitations
The study had a limited number of biopsies for validation, particularly in the CIN1 group.
Participant Demographics
Women referred for follow-up after abnormal or HPV-positive cytology, with a mean age of 35 years.
Statistical Information
P-Value
p < 0.001
Confidence Interval
95% CI, 0.86–0.95
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website